The Collaborative Islet Transplantation Registry Program
Page 2

The program also seeks to deeply comprehend the factors that contribute to the success and/or failure of islet transplantation protocols and more importantly, to develop approaches for continued improvements that could essentially result in sustained graft function and therapeutic durability.

The National Institutes of Health and the National Institute of Diabetes and Digestive and Kidney Diseases are willing to administer funds in the amount $2,650,000 to support the initiatives of the program.

The institutions and organizations who will be considered eligible to participate in this program are the following:

a) State Governments

b) County Governments

c) City or Township Govenments

d) Special District Governments

e) Independent School Districts

f) Public and State Controlled Institutions of Higher Education

g) Native American Tribal Governments

h) Public Housing Authorities/Indian Housing Authorities

i) Native American Tribal Organizations (other than Federally recognized tribal governments)

j) Nonprofit Organizations

k) Private Institutions of Higher Education

l) For-profit organizations other than small businesses

m) Small Businesses

The United States Department of Health and Human Services, the mother agency funding the The Collaborative Islet Transplantation Registry Program, is the country's leading program that's constantly working towards protecting the health of all Americans and providing fundamental human services to all.

The Collaborative Islet Transplantation Registry Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

The Collaborative Islet Transplantation Registry Program
The National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

---

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program.

---